Chemicals

1H-Benzimidazole-2-methanol

We are 1H-Benzimidazole-2-methanol CAS: 4856-97-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 4856-97-7

Product Name: 1H-Benzimidazole-2-methanol

Other Name:

(2-Benzimidazolyl)methanol

(1H-Benzoimidazol-2-yl)methanol

1H-benzimidazol-2-ylmethanol

2-(HydroxyMethyl)benziMidazole

2-Benzimidazolemethanol

2-hydroxymethyl-1H-benzimidazole

2-Hydroxymethylbenzimidazole

2-Benzimidazolemethanol

Density: 1.4±0.1 g/cm3

Boiling Point: 412.6±28.0 °C at 760 mmHg

Melting Point: 171-175 °C(lit.)

Molecular Formula: C8H8N2O

Molecular Weight: 148.162

Flash Point: 203.3±24.0 °C

Exact Mass: 148.063660

PSA: 48.91000

LogP: 0.67

Vapour Pressure: 0.0±1.0 mmHg at 25°C

Index of Refraction: 1.721

Specification

Appearance: White solid

Assay: ≥99.0%

Water: ≤0.50%

Application

Be used as pharmaceutical intermediate.

Package: 25kg/drum, can also be designed according to customer requirements.

Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

1H-Benzimidazole-2-methanol

Related News: The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.128625-52-5 The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.4-dimetilaminopiridina CAS:1122-58-3 With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. near2-Fluoropyridine-6-carboxylic acid APIs are generally manufactured through a variety of processes that include.Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”

Product Name
2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethanamine	View Details
1-Bromotetradecane	View Details
1,3-phenylenediamine	View Details